Oncology & Cancer

Cell therapy appears safe and effective for lymphoma in remission

A study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine suggests that CAR-T immunotherapy remains a viable option for patients who have lymphoma that goes into ...

page 2 from 23